|Day's Range||0.61 - 0.64|
|52 Week Range||0.15 - 11.03|
|PE Ratio (TTM)||-0.04|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Evolent Health, Inc. (EVH) recently announced the pricing of its follow-on public offering of 7.5 million shares of Class A common stock at $24.65 per share.
Genomic Health, Inc. (GHDX), a global cancer company, recently presented positive results for its Oncotype DX Genomic Prostate Score (GPS) test.
Thermo Fisher Scientific Inc. (TMO), a leading scientific instrument maker, recently agreed to acquire Netherlands-based Patheon N.V.